SCHEMBL30419982

SCHEMBL30419982

COCCS(=O)(=O)Nc1nccs1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKM P14618 5/20 0.49
ALDH1A1 P00352 3/20 0.49
MEN1 O00255 2/20 0.48
KMT2A Q03164 2/20 0.48
LMNA P02545 2/20 0.44
KDM4E B2RXH2 1/20 0.44
CYP2C9 P11712 1/20 0.44
EDNRA P25101 1/20 0.44
SLC6A4 P31645 1/20 0.44
ADRA1A P35348 1/20 0.44
PRMT6 Q96LA8 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
HSD17B10 Q99714 1/20 0.43
ACP1 P24666 1/20 0.42
SCN3A Q9NY46 1/20 0.41
SCN1A P35498 1/20 0.41
SCN1B Q07699 1/20 0.41
SCN5A Q14524 1/20 0.41
SCN8A Q9UQD0 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11979598 0.81 ALDH1A1 (0.50) PKMALDH1A1MEN1KMT2ALMNA
SCHEMBL5710108 0.79 ALDH1A1 (0.50) PKMALDH1A1MEN1KMT2ALMNA
SCHEMBL8796963 0.76 ALDH1A1 (0.49) PKMALDH1A1MEN1KMT2ALMNA
SCHEMBL11979597 0.74 ACP1 (0.53) PKMALDH1A1MEN1KMT2ALMNA
SCHEMBL2912774 0.73 ALDH1A1 (0.53) PKMALDH1A1MEN1KMT2ALMNA
SCHEMBL10419649 0.73 NAMPT (0.53) PKMALDH1A1MEN1KMT2ALMNA
SCHEMBL13574506 0.73 GAA (0.44) PKMALDH1A1MEN1KMT2ALMNA
SCHEMBL19700373 0.73 ALDH1A1 (0.49) PKMALDH1A1MEN1KMT2ALMNA
SCHEMBL2651756 0.72 PKM (0.56) PKMALDH1A1MEN1KMT2ALMNA
SCHEMBL30338934 0.71 EPHX2 (0.46) PKMALDH1A1MEN1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12503466-B2 Aminothiazole compounds as inhibitors of CTPS1 STEP PHARMA S.A.S. (FR) 2025-12-23 US disclosed
US-20240010645-A1 Aminothiazole Compounds as Inhibitors of CTPS1 STEP PHARMA S.A.S. (FR) 2024-01-11 US disclosed
US-11655246-B2 Aminothiazole compounds as inhibitors of CTPS1 STEP PHARMA S.A.S. (FR) 2023-05-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12503466-B2 Aminothiazole compounds as inhibitors of CTPS1 CTPS1, CTPS2, TBXAS1 PKM 3594/4885ALDH1A1 3425/4885MEN1 4301/4885
US-11655246-B2 Aminothiazole compounds as inhibitors of CTPS1 CTPS1, CTPS2, TBXAS1 PKM 3594/4885ALDH1A1 3425/4885MEN1 4301/4885
US-20240010645-A1 Aminothiazole Compounds as Inhibitors of CTPS1 CTPS1, CTPS2, TBXAS1 PKM 3594/4885ALDH1A1 3425/4885MEN1 4301/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.